Dosage form containing pantoprazole as active ingredient

US8703192B2 · kind B2 · utility

Assignee

• TAKEDA GMBH · DE

Inventors

• Isabel Anstett-Klein · Echterdingen, DE
• Rango Dietrich · Konstanz, DE
• Hartmut Ney · Konstanz, DE
• Marc SCHILLER · Aachen, DE
• Sabine Schaefer-Preuss · Singen, DE
• Manfred Hartmann · Konstanz, DE

Key dates

• Filing date: Apr 3, 2009
• Grant date: Apr 22, 2014
• Expiry date: Jun 30, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P1/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.